"India is witnessing an increasing trend of central nervous system...
Category:
Health
Latest
Over 11% Indians diabetic, 36 per cent have hypertension: Lancet survey shows
''The steep increase in NCDs can be attributed mostly to the...
Global Alzheimer’s disease market to reach $13.7bn by 2030: Report
The growth will be particularly seen across the eight major markets...
All passengers from UK to be tested for COVID-19 on arrival between Jan 8-Jan 30: Health ministry
If a passenger tests COVID-positive on arrival, passengers seated in the same row, three rows in front and three rows behind would also be subjected to institutional quarantine in separate quarantine centers, the SOP said.
The passengers who are found COVID-negative after the tests conducted at the airport would be advised home quarantine for 14 days and the concerned state or district administration should regularly follow up with them, it said.
India records less than 20,000 fresh COVID-19 cases; no. of recoveries goes past 99 lakh
The number of people who have recuperated from the disease surged to 99,06,387, pushing the national recovery rate to 96.12 per cent, while the COVID-19 case fatality rate stood at 1.45 per cent.
There are 2,50,183 active coronavirus cases in the country, which accounts for 2.43 per cent of the total caseload, the data stated.
Have to assume pandemic is going to get worse: Fauci
Fauci’s comments on Tuesday came after the US registered a record high 65,000 deaths in the past 28 days, making December the worst month for coronavirus fatalities since the start of the pandemic.
December’s figure, roughly equivalent to over 1.6 Americans lost to the virus every minute, marked a significant surge from that in the entire month of November which registered 36,964 fatalities.
The country’s overall the overall death toll currently stood at 338,544, the highest in the world, according to the Johns Hopkins University.
Study uncovers blood vessel damage, inflammation in COVID-19 patients’ brains
The researchers saw no signs of infection in the brain tissue samples even though they used several methods for detecting genetic material or proteins from SARS-CoV-2.
“So far, our results suggest that the damage we saw may not have been not caused by the SARS-CoV-2 virus directly infecting the brain,” said Dr. Nath. “In the future, we plan to study how COVID-19 harms the brain’s blood vessels and whether that produces some of the short- and long-term symptoms we see in patients.”
India drug regulator approves AstraZeneca COVID vaccine, country’s first
Cheaper and easier to distribute than rival shots, the AstraZeneca/Oxford vaccine could be a game-changer for global immunisation.
The Central Drugs Standard Control Organization is also considering emergency-use authorisation applications for vaccines made by Pfizer Inc with Germany’s BioNTech, and by India’s Bharat Biotech.
India wants to start administering the vaccine soon, most likely by Wednesday, said one of the sources, both of whom declined to be named ahead of an official announcement expected later in the day.
WHO emergency COVID-19 vaccine listing aims to lift access in poor countries
The United Nations health agency said it will work with regional partners to tell national health authorities about the two-dose shot and its anticipated benefits.
The WHO established its emergency use listing (EUL) process to help poorer countries without their own regulatory resources quickly approve medicines new diseases like COVID-19, which otherwise could lead to delays.
Drugmakers to hike prices for 2021 as pandemic, political pressure put revenues at risk
President-elect Biden has also vowed to reduce drug costs and to allow Medicare, a U.S. government health insurance program, to negotiate drug prices. He has support from Congressional Democrats to pass such legislation, which the Congressional Budget Office has said could cost the industry more than $300 billion by 2029.
BioNTech founders warn of vaccine supply gaps – Spiegel
“At the moment it doesn’t look good – a hole is appearing because there’s a lack of other approved vaccines and we have to fill the gap with our own vaccine,” BioNTech CEO Ugur Sahin told news weekly Spiegel.
Coronavirus vaccines could have potential allergic reactions, assures new studyBoston
The study published in the Journal of Allergy and Clinical Immunology, in response to accounts of potential allergic reactions in some people following COVID-19 vaccination in the United Kingdom, that country’s medical regulatory agency advised that individuals with a history of anaphylaxis to medicine or food should avoid COVID-19 vaccination.
U.S. COVID-19 cases surpass 20 million as deaths mount
A total of 345,000 have died of COVID-19, or one out of every 950 U.S. residents, since the virus first emerged in China late in 2019.
An analysis of Reuters data shows it took 200 days to reach the first 5 million cases, 93 days to go from 5 million cases to 10 million, 31 days from 10 million to 15 million cases and only 25 days to go from 15 million to 20 million cases.
California has the most total cases of any state, with about 2.28 million infections followed by Texas with 1.76 million cases and Florida with 1.32 million cases.